Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

By person

10 insiders · 6 transactions
91.6×

Robert Ragusa holds 91.6 times base salary in stock. $71.97M of shares against $785.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert Ragusa last reported holding, valued at $138.79, the price Common Stock was last bought or sold at on the open market here, on 15 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Joshua J. Ofman
Chief Executive Officer
—
$2.74M (6) scheduled
−$2.74M
342,271
0.7663%
$47.50M
−24.2%
Illumina, Inc. entity
10% owner
—
—
—
3,502,126
7.84%
$486.05M
−22.2%
Chun R Ding
10% owner
—
—
—
3,305,055
7.40%
$458.70M
−9.3%
Robert P Ragusa
Chief Executive Officer
—
—
—
518,582
1.16%
$71.97M
−15.4%
Aaron Freidin
Chief Financial Officer
—
—
—
225,364
0.5046%
$31.28M
−24.8%
Andrew John Partridge
Chief Growth Officer
—
—
—
155,865
0.3490%
$21.63M
−5.7%
Gregory L Summe
Director
—
—
—
45,909
0.1028%
$6.37M
+61.5%
William J Chase
Director
—
—
—
43,131
0.0966%
$5.99M
+55.5%
Steven Mizell
Director
—
—
—
42,978
0.0962%
$5.96M
+55.2%
Sarah Krevans
Director
—
—
—
42,628
0.0954%
$5.92M
+37.3%